Synthesis of n-substituted oligomers.
Abstract
Solid phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycols) (herein referred to as poly NSG) is used to obtain oligomers, such as poly NSG with potential therapeutic interest. These poly NSGs can have many different sled chain substituents. Each N-substituted glycine monomer is set up from two "sub-monomers" directly on the solid support. Each monomer addition cycle consists of two steps: (1) acylation of a second amine bonded to the support with an acylation agent comprising a cleavable group capable of nucleophile displacement of -NH such as halogen (as a resin-linked α-haloacetamide) with a sufficient amount of another sub-monomer comprising an -NH Repetition of the two-step cycle which includes acylation and displacement adds the desired oligomers. The efficient synthesis of various oligomeric NSGs using automated synthesis technology In accordance with the present invention, these oligomers make attractive candidates for the formation and rapid screening of various peptidomimetic libraries. The oligomers, then N-substituted glycines (i.e. poly NSG) provides a new class of peptide-containing compound not found in nature but which is synthetically obtainable and which has been shown to have significant biological activity and proteolytic stability.
Term
No projected expiry on record.
- Priority and filed
- Published
- Today
48 members in 17 offices
Members48
| Document | Office | Kind | |
|---|---|---|---|
| CA2144067A1 | Canada | A1 | |
| WO9406451A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5292093A | Australia | A | |
| NO950682D0 | Norway | D0 | |
| NO950682LThis record | Norway | L | |
| FI951356A | Finland | A | |
| FI951356A7 | Finland | A7 | |
| HU9500855D0 | Hungary | D0 | |
| PL308204A1 | Poland | A1 | |
| EP0671928A1 | European Patent Office (EPO) | A1 | |
| KR950703349A | Republic of Korea | A | |
| BG99521A | Bulgaria | A | |
| JPH08501565A | Japan | A | |
| HUT72614A | Hungary | A | |
| CA2221517A1 | Canada | A1 | |
| WO9640202A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6253496A | Australia | A | |
| EP0671928A4 | European Patent Office (EPO) | A4 | |
| AU679945B2 | Australia | B2 | |
| NZ256952A | New Zealand | A | |
| EP0789577A1 | European Patent Office (EPO) | A1 | |
| EP0789577A4 | European Patent Office (EPO) | A4 | |
| US5831005A | United States of America | A | |
| KR0168709B1 | Republic of Korea | B1 | |
| US5877278A | United States of America | A | |
| BR9307092A | Brazil | A | |
| JPH11507049A | Japan | A | |
| US5977301A | United States of America | A | |
| JP2000239242A | Japan | A | |
| US2002115612A1 | United States of America | A1 | |
| EP1258492A1 | European Patent Office (EPO) | A1 | |
| EP0671928B1 | European Patent Office (EPO) | B1 | |
| AT228532T | Austria | T | |
| ATE228532T1 | Austria | T1 | |
| JP2003012622A | Japan | A | |
| DE69332524D1 | Germany | D1 | |
| EP0789577B1 | European Patent Office (EPO) | B1 | |
| AT234268T | Austria | T | |
| ATE234268T1 | Austria | T1 | |
| DE69332524T2 | Germany | T2 | |
| DE69626621D1 | Germany | D1 | |
| HK1049173A1 | Hong Kong, China | A1 | |
| JP3461505B2 | Japan | B2 | |
| DE69626621T2 | Germany | T2 | |
| JP3596752B2 | Japan | B2 | |
| JP2006182780A | Japan | A | |
| JP3943593B2 | Japan | B2 | |
| CA2221517C | Canada | C |
Numbers
- Application
- 950682
Titles2
- English
- Synthesis of N-substituted oligomers
- Norwegian
- Syntese av N-substituerte oligomerer
Classification
- CPC, 9
- A61K38/00
- C07K7/06
- B01J2219/00497
- B01J2219/00596
- B01J2219/0072
- C07K1/04
- C07K7/08
- C07K14/001
- C08G69/10
- IPC, 20
- C07C231 12
- A61K31 708
- A61K31 785
- A61K38 00
- A61K38 16
- A61K39 00
- A61K39 395
- A61K48 00
- C07B43 06
- C07C231 02
- C07C237 22
- C07C237 42
- C07K
- C07K1 04
- C07K1 08
- C07K7 06
- C07K7 08
- C07K14 00
- C08G69 08
- C08G69 10